ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of the Addition of Alanyl-Glutamine-Dipeptide to Dialysis Solution in Peritoneal Dialysis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01353638
Recruitment Status : Terminated (Primary endpoint (HSP) could not be analyzed with the specified method in the planned interim analysis; a method of increased sensitivity had to be established.)
First Posted : May 13, 2011
Last Update Posted : September 11, 2015
Sponsor:
Information provided by (Responsible Party):
Christoph Aufricht, Medical University of Vienna

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : March 2012
  Actual Study Completion Date : May 2012